drugset / Trial / NCT05434494

The Effect of Remifentanil on ED95 of Remimazolam for Loss of Consciousness in Adult Patients

NCT05434494

RandomizedParallel-groupQuadruple-blindOther

Summary

This study prospectively uses the biased coin technique to investigate the effect of concomitant administration of remifentanil on the 95% effective dose of intravenous remimazolam (Effective dose 95 \[ED95\]) required for loss of consciousness during anesthesia induction. .

Timeline

Start
2022-07-01
Primary completion
2023-07-30
Completion
2023-08-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Remimazolam Small molecule 0.15 mg/kg Intravenous
Comparator remifantanil Unknown

Indications

No indication recorded.